25 Mar 2026
// PRESS RELEASE
18 Mar 2026
// PRESS RELEASE
13 Nov 2025
// PRESS RELEASE
Latest Content by PharmaCompass
About
CDMO Live Europe 2026CDMO Live Europe 2026
Industry Trade Show
Attending
19-21 May, 2026
PHARM Connect CongressPHARM Connect Congress
Industry Trade Show
Attending
20-21 May, 2026
Industry Trade Show
Booth #3H83
06-08 October, 2026
CONTACT DETAILS







Events
Webinars & Exhibitions
CDMO Live Europe 2026CDMO Live Europe 2026
Industry Trade Show
Attending
19-21 May, 2026
PHARM Connect CongressPHARM Connect Congress
Industry Trade Show
Attending
20-21 May, 2026
Industry Trade Show
Booth #3H83
06-08 October, 2026

25 Mar 2026
// PRESS RELEASE
https://www.caymanchem.com/news/standards-to-support-cfsre-nps-scope-recommendations

18 Mar 2026
// PRESS RELEASE

13 Nov 2025
// PRESS RELEASE

11 Nov 2025
// PRESS RELEASE
https://www.caymanchem.com/news/new-product-spotlight-biofilm-formation-and-staining-kit

24 Oct 2025
// PRESS RELEASE
https://www.caymanchem.com/news/serum-albumins-as-carriers-for-fatty-acid-delivery

27 Sep 2025
// PRESS RELEASE
https://www.caymanchem.com/news/advancing-cell-and-gene-therapy-development-with-akadeum-partnership
GDUFA
DMF Review : Complete
Rev. Date : 2013-09-10
Pay. Date : 2013-08-16
DMF Number : 17445
Submission : 2004-06-01
Status : Active
Type : II
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Certificate Numbers : CEP 2022-093 - Rev 01
Status : Valid
Issue Date : 2024-11-25
Type : Chemical
Substance Number : 2230
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Registration Number : 221MF10182
Registrant's Address : 1180 E. Ellsworth Road, Ann Arbor, MI 48108, USA
Initial Date of Registration : 2009-08-13
Latest Date of Registration : 2009-08-13
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Registration Number : 220MF10211
Registrant's Address : 1180 E. Ellsworth Road, Ann Arbor, MI 48108, USA
Initial Date of Registration : 2008-10-10
Latest Date of Registration : 2008-10-10
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Registrant Name : Santen Korea Co., Ltd.
Registration Date : 2023-11-20
Registration Number : Su139-6-ND
Manufacturer Name : Cayman Chemical Company
Manufacturer Address : 1180 E. Ellsworth Road Ann Arbor, MI 48108 USA
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
About the Company : Our mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare...
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
About the Company : Our mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare...
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
About the Company : Our mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare...
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
About the Company : Our mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
The grant will be used to explore Cayman’s patented small molecule bone repair agent KMN-159 as the active pharmaceutical ingredient (API) in a drug-device combination to improve the mechanical anchorage of dental titanium implants into the jawbone.
Lead Product(s): KMN-159,Collagen
Therapeutic Area: Musculoskeletal Brand Name: Undisclosed
Study Phase: PreclinicalProduct Type: Miscellaneous
Sponsor: NIDCR
Deal Size: $1.7 million Upfront Cash: Undisclosed
Deal Type: Funding September 16, 2021
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : KMN-159,Collagen
Therapeutic Area : Musculoskeletal
Highest Development Status : Preclinical
Partner/Sponsor/Collaborator : NIDCR
Deal Size : $1.7 million
Deal Type : Funding
Cayman Receives Grant to Evaluate Use of KMN-159 to Accelerate Dental Implant Osseointegration
Details : The grant will be used to explore Cayman’s patented small molecule bone repair agent KMN-159 as the active pharmaceutical ingredient (API) in a drug-device combination to improve the mechanical anchorage of dental titanium implants into the jawbone.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Undisclosed
September 16, 2021
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
The funding will be used to develop an assay platform and novel antibodies to support the treatment, prevention, and early diagnosis of Alzheimer’s disease and other tauopathies.
Lead Product(s): Undisclosed
Therapeutic Area: Neurology Brand Name: Undisclosed
Study Phase: PreclinicalProduct Type: Undisclosed
Sponsor: SBIR
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Funding October 08, 2020
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Undisclosed
Therapeutic Area : Neurology
Highest Development Status : Preclinical
Partner/Sponsor/Collaborator : SBIR
Deal Size : Undisclosed
Deal Type : Funding
Cayman Receives SBIR Grant for Alzheimer’s Research
Details : The funding will be used to develop an assay platform and novel antibodies to support the treatment, prevention, and early diagnosis of Alzheimer’s disease and other tauopathies.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Undisclosed
October 08, 2020
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
Cayman Chemical Company Inc is a supplier offers 7 products (APIs, Excipients or Intermediates).
Find Latanoprost bulk with DMF, CEP, JDMF offered by Cayman Chemical Company Inc
Find Latanoprost bulk with JDMF offered by Cayman Chemical Company Inc
Find Dimethyltryptamine bulk offered by Cayman Chemical Company Inc
Find Midomafetamine bulk offered by Cayman Chemical Company Inc
Find Netarsudil Mesylate bulk offered by Cayman Chemical Company Inc
Find Psilocin bulk offered by Cayman Chemical Company Inc
Find Retatrutide bulk offered by Cayman Chemical Company Inc
Cayman Chemical Company Inc



